European Federation of Allergy and Airways Diseases Patients Associations

Recent papers from European Federation of Allergy and Airways Diseases Patients Associations

1. The SISAQOL-IMI glossary: harmonising terminology for patient-reported outcomes in cancer clinical trialsJournal of Patient-Reported Outcomes · 2026
2. Practical recommendations for the implementation of shared decision-making in multiple myeloma carePLoS ONE · 2026
3. Enhancing patient involvement through shared decision-making: Are we there yet in multiple myeloma? Findings from a cross-country surveyPLoS ONE · 2026
4. Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summaryExpert Opinion on Biological Therapy · 2026
5. Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global RelevanceClinical Pharmacology & Therapeutics · 2026
6. Ten tips for the diagnosis and management of fibromuscular dysplasiaClinical Kidney Journal · 2026
7. Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled TrialsPulmonary Therapy · 2026
8. Remission in Global Airway Diseases: EUFOREA Consensus PaperAllergy · 2026
9. Supporting the Implementation and Addressing the Challenges of the EU HTA RegulationJournal of Market Access & Health Policy · 2026
10. Building capacity for patient advocacy in liver health: a cross-country qualitative studyBMJ Open · 2026
11. From Participation to Evidence: Listening‐Informed Policies and the Epistemic Role of Lived Experience in Population HealthHealth Expectations · 2026
12. A36-22 A Patient Charter for People Living With Chronic Rhinosinusitis With Nasal Polyps: Multinational Perspectives From the Gaapp Community SurveyAmerican Journal of Respiratory and Critical Care Medicine · 2026
13. C35-27 Initial Patient Impressions Reflect Improved Well-Being, Activity, and Independence Following Treatment With Ohtuvayre: A Global Allergy and Airways Patient Platform (GAAPP) Focus GroupAmerican Journal of Respiratory and Critical Care Medicine · 2026
14. B15-03 Astegolimab Decreases Exacerbation Risk in Patients With COPD With Frequent Exacerbations, Irrespective of Blood Eosinophil Count: Pooled Analysis of the Pivotal Randomized Trials ALIENTO and ARNASAAmerican Journal of Respiratory and Critical Care Medicine · 2026
15. C37-05 Attitudes Toward Vaccines and Antivirals for Viral Respiratory Infections in a Survey of U.S. Adults With Chronic Lung ConditionsAmerican Journal of Respiratory and Critical Care Medicine · 2026
16. C37-06 Vaccines Perceptions, Capacities, and Barriers Faced in Latin American Communities: A Study From Patient Organizations and Social Community LeadersAmerican Journal of Respiratory and Critical Care Medicine · 2026
17. Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA TrialsAmerican Journal of Respiratory and Critical Care Medicine · 2026
18. CVOT Summit Report 2025: advances along the cardiovascular–kidney–metabolic disease continuumCardiovascular Diabetology · 2026
19. Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trialsEuropean Journal of Cancer · 2026
20. The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignanciesHemaSphere · 2026